THERAVANCE
Live / Registered — Registered and renewed (as of 13 Aug 2024)
What this means for you
Registered since 02 Dec 2014. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Dec 2024).
Record
- Serial number
- 86248947
- Registration number
- 4648559
- Mark type
- Stylized text
- Filed
- 10 Apr 2014
- Published for opposition
- 16 Sept 2014
- Registered
- 02 Dec 2014
- Next maintenance due
- 02 Dec 2024
- Attorney of record
- Michele M. Glessner
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders
Owner
- THERAVANCE BIOPHARMA R&D IP, LLC, SOUTH SAN FRANCISCO, CA, US
- THERAVANCE BIOPHARMA R&D IP, LLC, SOUTH SAN FRANCISCO, CA, US
- THERAVANCE BIOPHARMA R&D IP, LLC, SOUTH SAN FRANCISCO, CA, US
- Theravance, Inc., South San Francisco, CA, US
Prior registrations
Prosecution history
- 13 Aug 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 13 Aug 2024 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 13 Aug 2024 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 30 Jul 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 09 May 2024 — TEAS SECTION 8 & 9 RECEIVED
- 02 Dec 2023 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 17 Dec 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 17 Dec 2020 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 17 Dec 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 29 Sept 2020 — TEAS SECTION 8 & 15 RECEIVED
- 02 Dec 2014 — REGISTERED-PRINCIPAL REGISTER
- 16 Sept 2014 — PUBLISHED FOR OPPOSITION
- 27 Aug 2014 — NOTICE OF PUBLICATION
- 14 Aug 2014 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 13 Aug 2014 — ASSIGNED TO LIE